Pharmabid, LLC Sustainability Profile
Pharmabid, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States and operates across key regions globally. Founded in 2015, the company has rapidly established itself as a leader in pharmaceutical procurement and supply chain solutions, catering to a diverse clientele that includes healthcare providers and pharmaceutical manufacturers. Specialising in innovative bidding platforms, Pharmabid offers unique services that streamline the procurement process, ensuring efficiency and cost-effectiveness. The company’s commitment to transparency and competitive pricing has positioned it favourably within the market, earning recognition for its robust technology and customer-centric approach. With a focus on enhancing accessibility to essential medications, Pharmabid continues to make significant strides in the healthcare landscape.
DitchCarbon Score
How does Pharmabid, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmabid, LLC's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmabid, LLC's reported carbon emissions
Pharmabid, LLC, headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of reported emissions data and reduction initiatives, Pharmabid's climate commitments remain unclear. The company may be in the early stages of developing its sustainability strategy or may not yet have publicly disclosed its climate-related efforts. As the pharmaceutical industry increasingly focuses on reducing carbon footprints, it is essential for Pharmabid to consider establishing measurable targets and reporting frameworks to align with industry standards and expectations.
How Carbon Intensive is Pharmabid, LLC's Industry?
How Carbon Intensive is Pharmabid, LLC's Location?
Pharmabid, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmabid, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
